Ex vivo hepatocyte gene therapy: Increased biosafety protocol for transduction in suspension with lentiviral vectors and immediate transplantation (SLIT)

Transplantation

Volumn 89, Issue 1, 2010, Pages 127-129

  Birraux, Jacques ^a,b,c   Wildhaber, Barbara E ^a,b,c   Jond, Caty ^b   Menzel, Olivier ^b   Belli, Dominique C ^a,c,d  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; SERINE PROTEINASE;

CELL BASED GENE THERAPY; CELL VIABILITY; HUMAN; LETTER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL SURVIVAL; CONTAINMENT OF BIOHAZARDS; GENE THERAPY; HEPATOCYTES; HUMANS; LENTIVIRUS INFECTIONS; LIVER DISEASES; LIVER TRANSPLANTATION; RATS; RATS, WISTAR; SERINE PROTEASES; TRANSPLANTATION, AUTOLOGOUS; TRYPSIN;

EID: 74549138228     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181c28118     Document Type: Letter

References (7)

1. Menzel O, Birraux J, Wildhaber BE, et al. Biosafety in ex vivo gene therapy and conditional ablation of lentivirally transduced hepatocytes in nonhuman primates. Mol Ther 2009; 17: 1754.
2. Birraux J, Menzel O, Wildhaber B, et al. A step toward liver gene therapy: Efficient correction of the genetic defect of hepatocytes isolated from a patient with Crigler-Najjar syndrome type 1 with lentiviral vectors. Transplantation 2009; 87: 1006.
3. Costa RH, Grayson DR. Site-directed mu-tagenesis ofhepatocyte nuclear factor (HNF) binding sites in the mouse transthyretin (TTR) promoter reveal synergistic interactions with its enhancer region. Nucleic Acids Res 1991; 19: 4139.
4. Pan YW, Scarlett JM, Luoh TT, et al. Prolonged adherence of human immunodeficiency virus-derived vector particles to hematopoietic target cells leads to secondary transduction in vitro and in vivo. J Virol 2007; 81: 639.
5. DePolo NJ, Reed JD, Sheridan PL, et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2000; 2: 218.
6. Seppen J, van der Rijt R, Looije N, et al. Long-term correction of bilirubin UDPglucuronyl-transferase deficiency in rats by in utero lenti-viral gene transfer. Mol Ther 2003; 8: 593.
7. Nguyen TH, Birraux J, Wildhaber B, et al. Ex vivo lentivirus transduction and immediate transplantation of uncultured hepatocytes for treating hyperbilirubinemic Gunn rat. Transplantation 2006; 82: 794.